SoftVue 3D (ultrasound scanner)

2021: Announcement of an ultrasound scanner for breast cancer search in 3D format

On October 12, 2021, Delphinus Medical Technologies announced the release of an ultrasound tomography system for all breast SoftVue 3D as a supplement to digital mammography when examining asymptomatic cases in women with dense breast tissue.

Clinical data have shown that SoftVue improves dense breast screening and detects up to 20% more cancerous tumors with greater accuracy and potentially fewer biopsies than full-field digital mammography (FFDM) alone.

Ultrasound Scanner SoftVue 3D

The SoftVue system was designed to meet clinical needs for early detection of breast cancer in individuals with dense tissue and represents a new solution for annual screening for this population. The system detects more cancers with fewer callbacks using patented triple acoustic detection (TriAD) technology that effectively characterizes tissues by recording the reflection, velocity, and direction of sound waves passing through breast tissues as opposed to traditional ultrasound that uses only reflection. SoftVue detects and distinguishes between normal (BI-RADS 1 and 2) and abnormal (BI-RADS 3 and 4) lesions with a 20% increase in sensitivity and 8% specificity compared to FFDM alone. In addition, 95% of patients surveyed after a SoftVue examination said they would recommend SoftVue to other women.

During the study, the patient relaxes on her stomach, and her chest is immersed in a bath with warm water. The chest is conveniently stabilized and centered with the Sequr Breast Interface disposable gel pad. Visualization is done with a patented 360-degree angle ring sensor that scans the chest from the chest wall to the nipple in an average of three minutes, obtaining new images every two millimeters. The obtained signals are then analyzed using complex algorithms that allow to obtain cross-sectional sections of the entire volume of breast tissue.

According to official sources, by health care USA 2021, 40% of women in the country have dense breast tissue, so the increased risk, combined with reduced sensitivity, poses significant problems for this population.^[1][2]

Notes